A partnership between two innovative start-ups leads the way for advancing patient access to psychedelic medicines in Europe. According to a statement released today, Copenhagen-based Octarine Bio, has partnered with clinical research organisation Clerkenwell Health to deliver clinical trials. Octarine Bio is a synthetic biology drug development company that produces psilocybin from sugar using fermentation. […] The post British start-up to help deliver innovative psychedelics to patients appeared first on Canex.
Excerpt only …
READ MORE BELOW
Source : British start-up to help deliver innovative psychedelics to patients
reposted by Cannabis News World